Introduction The prevalence of cirrhosis in the US has almost doubled in the last decade, resulting in a substantial rise in its associated morbidity and mortality.(1, 2) As many as half of patients with cirrhosis develop clinical complications, including variceal hemorrhage, ascites, hepatic encephalopathy (HE), and hepatocellular carcinoma. The health burden of cirrhosis is amplified by its dramatic impact on patients’ health related quality of life (HRQOL), resulting from a range of physical, psychological, and social stressors engendered by cirrhosis and its treatment.